Focus on type 2 diabetes, metabolic syndrome and cardiovascular risk

被引：0
|
作者：
机构：
来源：
POST ACCORD PERSPECTIVES: THE ROLE OF FENOFIBRATES: TRANSLATING THE EVIDENCE-BASED MEDICINE AND SCIENCE INTO CLINICAL PRACTICE FOR THE PRIMARY CARE PROVIDER | 2010年 / 274卷
关键词：
INSULIN-RESISTANCE; DISEASE; MORTALITY; MELLITUS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：20 / 25
页数：6
相关论文
共 50 条
  • [41] Metabolic syndrome accounts for increased risk of type 2 diabetes or cardiovascular disease associated with overall obesity
    Meigs, JB
    Wilson, PW
    Sullivan, L
    Fox, CS
    D'Agostino, RB
    CIRCULATION, 2005, 111 (14) : E200 - E200
  • [42] Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes
    Guzder, RN
    Gatling, W
    Mullee, MA
    Byrne, CD
    DIABETOLOGIA, 2006, 49 (01) : 49 - 55
  • [43] Prevalence of cardiovascular risk factors and metabolic syndrome in patients with type 2 diabetes mellitus in cardiac rehab
    Blanc, Philippe
    Boussuges, Alain
    Maunier, Sebastien
    Chopra, Soeb
    Debussche, Xavier
    DIABETES, 2007, 56 : A589 - A589
  • [44] Assessment of Cardiovascular Risk in Adults With Type 2 Diabetes and Metabolic Syndrome Framingham Versus UKPDS Equations
    Kim, Chun-Ja
    Kang, Hee Sun
    Schlenk, Elizabeth A.
    Chae, Sun-Mi
    DIABETES EDUCATOR, 2015, 41 (02): : 203 - 213
  • [45] Methodology for the analysis of type 2 diabetes, metabolic syndrome and cardiovascular disease risk indicators in the ENSANUT 2006
    Barquera, Simon
    Campos-Nonato, Ismael
    Carrion-Rabago, Citlali
    Villalpando, Salvador
    Lopez-Ridaura, Ruy
    Rojas, Rosalba
    Aguilar-Salinas, Carlos A.
    SALUD PUBLICA DE MEXICO, 2010, 52 : S4 - S10
  • [46] Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes
    R. N. Guzder
    W. Gatling
    M. A. Mullee
    C. D. Byrne
    Diabetologia, 2006, 49 : 49 - 55
  • [47] Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
    Ogedengbe, O. Stephen
    Ezeani, Ignatius U.
    Chukwuonye, Ijezie I.
    Anyabolu, Ernest N.
    Ozor, Ikemefuna I.
    Eregie, Aihanuwa
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2015, 8 : 437 - 445
  • [48] Reducing cardiovascular disease risk in type 2 diabetes: is the focus on glycaemia warranted?
    Ferguson, L. D.
    Sattar, N.
    DIABETES OBESITY & METABOLISM, 2013, 15 (05): : 387 - 391
  • [49] Addressing Cardiovascular Risk in Patients With Type 2 Diabetes: Focus on Primary Care
    Stolar, Mark
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 341 (02): : 132 - 140
  • [50] COMPREHENSIVE CARDIOVASCULAR RISK REDUCTION IN THE METABOLIC SYNDROME AND DIABETES
    Sperling, L. S.
    CARDIOLOGY, 2016, 134 : 83 - 83
12345